Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Aubrey Rankin currently holds 94,091 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aubrey Rankin has been a net seller of RVNC stock. They have purchased $432.9K and sold $8.7M worth of shares.
Aubrey Rankin's most recent insider trade was on Mar 15, 2022, when they sold 1,372 shares at $15.79 per share.
Aubrey Rankin serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 19 insider transactions totaling $9.1M over their tenure at the company.
Aubrey Rankin holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Aubrey Rankin has shown a selling trading pattern, with $432.9K in total purchases and $8.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Aubrey Rankin was on Jul 26, 2021, when they sold $1.6M worth of RVNC shares. This transaction involved 55,382 shares at $29.72 per share.
Aubrey Rankin currently owns 94,091 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Aubrey Rankin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Aubrey Rankin has 19 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for Aubrey Rankin and 40,000+ other insiders.